Geode Capital Management’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$382K Buy
56,154
+1,981
+4% +$14.1K ﹤0.01% 3665
2026
Q2
$429K Buy
54,173
+1,991
+4% +$13.5K ﹤0.01% 3662
2026
Q1
$347K Buy
52,182
+42,347
+431% +$289K ﹤0.01% 3708
2025
Q4
$65K Buy
9,835
+5,181
+111% +$41K ﹤0.01% 4189
2025
Q3
$36.1K Sell
4,654
-4,759
-51% -$64.6K ﹤0.01% 4355
2025
Q2
$134K Sell
9,413
-10
-0.1% -$146 ﹤0.01% 3989
2025
Q1
$123K Buy
9,423
+651
+7% +$9.5K ﹤0.01% 3978
2024
Q4
$129K Sell
8,772
-82
-0.9% -$1.86K ﹤0.01% 4031
2024
Q3
$288K Buy
8,854
+158
+2% +$4.3K ﹤0.01% 3781
2024
Q2
$205K Sell
8,696
-302
-3% -$11.2K ﹤0.01% 3898
2024
Q1
$353K Buy
8,998
+3,265
+57% +$95.6K ﹤0.01% 3737
2023
Q4
$107K Buy
5,733
+4,264
+290% +$83.6K ﹤0.01% 4171
2023
Q3
$82.9K Sell
1,469
-439
-23% -$43.9K ﹤0.01% 4308
2023
Q2
$196K Hold
1,908
– – ﹤0.01% 4053
2023
Q1
$192K Hold
1,908
– – ﹤0.01% 4071
2022
Q4
$192K Hold
1,908
– – ﹤0.01% 4125
2022
Q3
$187K Buy
1,908
+558
+41% +$54.8K ﹤0.01% 4253
2022
Q2
$132K Hold
1,350
– – ﹤0.01% 4468
2022
Q1
$131K Buy
+1,350
New +$131K ﹤0.01% 4556

Other funds holding COCH

Geode Capital Management's COCH Position: Q3 2026 in Review

Geode Capital Management increased its Envoy Medical (COCH) stake by 3.7% in Q3 2026, buying an estimated $14.1K and bringing the position to 56,154 shares worth $382K. The position accounts for ﹤0.01% of the portfolio, ranked #3665.

Geode Capital Management first reported a position in COCH in Q1 2022 and has held it in 19 quarters since. The position peaked at $429K in Q2 2026. 31 funds tracked by Wall St. Rank hold COCH as of Q3 2026.

  • Geode Capital Management held 56,154 shares of Envoy Medical worth $382K as of Q3 2026.
  • Geode Capital Management bought 1,981 Envoy Medical shares in Q3 2026, an estimated $14.1K.
  • Envoy Medical made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3665 holding.
  • Geode Capital Management first reported a position in Envoy Medical in Q1 2022 and has held it in 19 quarters since.
  • Geode Capital Management's Envoy Medical position peaked at $429K in Q2 2026.
  • 31 funds tracked by Wall St. Rank held Envoy Medical as of Q3 2026.

Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.